Featured Jobs
|
Relationship Manager for Defined Contributions Daybright Financial
|
|
July Business Services
|
|
Heller Pension Associates, Inc.
|
|
Senior ERISA Compliance Analyst Employee Fiduciary, LLC
|
|
Independent Retirement
|
|
Retirement Compliance Consultant Navia Benefit Solutions
|
|
Daybright Financial
|
|
Executive Assistant / Sales Support M2B Retirement Consulting LLC
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
|
EPIC RPS
|
|
Relationship Manager for Defined Benefits Daybright Financial
|
|
Senior Counsel - Benefits and Total Rewards Tyson Foods
|
|
MAP Retirement
|
|
Retirement Plan Installation & Document Manager Fringe Benefit Group
|
Free Publications
|
|
2026 GLP-1 Outlook: A Strategic Roadmap to Manage Spend and Trend (PDF)
CVS Caremark 
May 13, 2026 "[CVS expects] a ~15% decrease in the per prescription net cost in 2026 compared to 2025 for commercial template formulary clients with Standard Utilization Management (UM).... Even with lower net costs per prescription, [CVS expects] overall category spend to rise ~10% for clients maintaining their current benefit designs.* This reflects higher utilization and expanded eligibility." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |